Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Genetic Analysis

0.76 NOK

+4.11 %

Less than 1K followers

GEAN

Spotlight Stock Market

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
+4.11 %
-4.40 %
-10.59 %
-27.62 %
+49.02 %
+38.18 %
-67.66 %
-
-92.90 %

Genetic Analysis operates in the medical technology sector. The company conducts research and development in the field of diagnostics, with the greatest focus on the human microbiome. The technology is based on the company's research platform and the IVD products are used, for example, for testing and analysis of bacteria and viruses. The largest operations are found in the Nordic market and the products are mainly resold to laboratories. The company is headquartered in Oslo, Norway.

Read more
Market cap
52.51M NOK
Turnover
10.74K NOK
Revenue
15.89M
EBIT %
-89.49 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
25/2
2026

Annual report '25

All
Press releases
3rd party
ShowingAll content types
Press release12/5/2025, 9:45 AM

Analyst Group: Equity Research Report on Genetic Analysis - Expands the Product Portfolio

Genetic Analysis
Press release11/27/2025, 12:33 PM

Analyst Group: Analyst Group Comment on Genetic Analysis Q3-report Report 2025

Genetic Analysis
Regulatory press release11/27/2025, 7:00 AM

Genetic Analysis AS: Publication of interim report Q3 2025

Genetic Analysis

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release11/17/2025, 1:41 PM

Analyst Group: Analyst Group Comment on Genetic Analysis Announced Milestone Regarding GA-map® IBD Precision Dx

Genetic Analysis
Regulatory press release11/17/2025, 7:00 AM

Genetic Analysis AS announces milestone in the IBD diagnostic test development project - completion of biomarker panel for GA-map® IBD Precision Dx

Genetic Analysis
Press release9/24/2025, 8:56 AM

Analyst Group: Comment on Genetic Analysis Launch of GA-map® MHI GutHealth Reagent kit

Genetic Analysis
Regulatory press release9/24/2025, 6:00 AM

Genetic Analysis AS launches the GA-map® MHI GutHealth reagent kit

Genetic Analysis
Press release9/5/2025, 9:48 AM

Analyst Group: Equity Research Report on Genetic Analysis - Accelerates Growth in the U.S.

Genetic Analysis
Press release8/28/2025, 12:26 PM

Analyst Group: Analyst Group Interview Genetic Analysis CEO Ronny Hermansen

Genetic Analysis
Press release8/27/2025, 12:51 PM

Analyst Group: Analyst Group Comment on Genetic Analysis Q2-report Report 2025

Genetic Analysis
Regulatory press release8/27/2025, 6:00 AM

Genetic Analysis AS: Publication of Half-year report 2025

Genetic Analysis
Press release7/30/2025, 8:57 AM

Analyst Group: Analyst Group Comment on Genetic Analysis Launch of GA-map® MHI GutHealth in the USA

Genetic Analysis
Regulatory press release7/29/2025, 6:30 AM

Genetic Analysis AS and Pangea Laboratory LLC announces the launch of GA-map® MHI GutHealth in the USA

Genetic Analysis
Regulatory press release6/27/2025, 1:10 PM

Genetic Analysis AS: Genetic Analysis subsequent offering to existing shareholders has now been registered with the Norwegian Register of Business Enterprises

Genetic Analysis
Regulatory press release6/18/2025, 8:40 AM

Genetic Analysis AS: Genetic Analysis announces final outcome of the subsequent offering to existing shareholders

Genetic Analysis
Regulatory press release6/18/2025, 7:30 AM

Genetic Analysis AS: Genetic Analysis: Direct issue has now been registered with the Norwegian Register of Business Enterprises

Genetic Analysis
Regulatory press release6/16/2025, 2:30 PM

Genetic Analysis AS: Genetic Analysis announces preliminary outcome of the subsequent offering to existing shareholders

Genetic Analysis
Regulatory press release6/12/2025, 11:10 AM

Genetic Analysis AS: Mandatory notification of trade

Genetic Analysis
Regulatory press release6/12/2025, 6:00 AM

Genetic Analysis AS: Today is the last day for trading in the subscription rights for subscribing for shares in Genetic Analysis

Genetic Analysis
Press release6/6/2025, 1:09 PM

Analyst Group: Analyst Group Interview Genetic Analysis CEO Ronny Hermansen

Genetic Analysis
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.